t(8;13)(p11;q12) ZMYM2/FGFR1

2000-12-01   Marie-Josçphe Pébusque  , Marie-Josçphe Pébusque  

1.INSERM U119, IFR 57, 27 Blvd Lei Roure, 13009 Marseille, France
2.Lymphoma Research Group - Groupe de Recherche sur les Lymphomes, Institut Albert Bonniot, La Tronche 38706, France (DL)

Clinics and Pathology

Disease

a myeloproliferative disorder that is frequently associated with T cell, or less commonly, B-cell non Hodgkin lymphoma

Phenotype stem cell origin

may involve a stem cell involving both myeloid, T lineage, and B-cell lineage

Epidemiology

14 cases are described; median age 43 yrs (range 18-68); sex ratio: 6M/8F

Clinics

aggressive disease; complex picture of myeloid hyperplasia progressing to myelodysplasia and Tor -B- cell lymphoma; enlarged lymph node; blood data: high WBC (median 40 X 109/l); myelemia; monocytosis and eosinophilia

Evolution

the disease transforms to AML, or occasionally ALL, in a median of 6 months

Prognosis

median survival: 12 months

Cytogenetics

Cytogenetics morphological

the same t(8;13) is found both in the bone marrow and in the lymph node, ruling out the hypothesis of a leukemoid reaction caused by a lymphoma; the multilineage involvement suggests the malignant transformation of a primitive hematopoietic stem cell.

Additional anomalies

usually occurs as a single anomaly; duplication of the der(13) was found during disease progression, suggesting that the crucial event might lie on this derivative chromosome; +8, +21 are also recurrently found

Genes Involved and Proteins

Gene name
FGFR1 (Fibroblast Growth Factor Receptor 1)
Location
8p11.23
Gene name
ZMYM2 (fused in myeloproliferative disorders).
Location
13q12.11
Protein description
zinc finger protein (ten repeats in the N-terminal region with the consensus sequence C-X2-C-X18-24-(F/Y)-C-X3-C that corresponds to a novel type of zing finger motifs), a hydrophobic repeat (proline-rich), and potentially two putative nuclear localisation signals

Result of the Chromosomal Anomaly

Atlas Image

Description

breakpoint in FGFR1 intron 8Aberrant tyrosine kinase composed of the N-term two-thirds of FIM (retaining the 10 putative zinc finger motifs), and the FGFR1 intracellular region minus the major part of the juxtamembrane domain (and deleting the N-term immunoglobulin-like and central transmembrane domains of FGFR1)

Expression localisation

cytoplasmic

Oncogenesis

through constitutive activation of FGFR1 signal transduction pathways, possibly via dimerization capability mediated by the FIM N-term sequences of the fusion protein

Highly cited references

Pubmed IDYearTitleCitations
272451472016FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).130
215275312011Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease.25
228756132013Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.23
228756282013Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements.15
205549712010Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.13
270059992016Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.12
285513292017Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.7
340274172021Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.6
237518922013A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment.5
222368112012Submicroscopic deletion of FGFR1 gene is recurrently detected in myeloid and lymphoid neoplasms associated with ZMYM2-FGFR1 rearrangements: a case study.3
274151552016Diagnostic application of next-generation sequencing in ZMYM2-FGFR1 8p11 myeloproliferative syndrome: A case report.2
291076672018FGFR1 translocation with concurrent myeloproliferative neoplasm, systemic mastocytosis, and lymphoblastic lymphoma: a case report.1
350133002022A proximity biotinylation-based approach to identify protein-E3 ligase interactions induced by PROTACs and molecular glues.0
301605872019ZMYM2-FGFR1 fusion as secondary change in acute myeloid leukemia.0
2756909920168p11 myeloproliferative syndrome: diagnostic challenges and pitfalls.0

Article Bibliography

Pubmed IDLast YearTitleAuthors
93765941997Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.Aguiar RC et al
98890061999The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.Kulkarni S et al
104809031999Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation.Ollendorff V et al
95769491998Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).Popovici C et al
97166031998Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.Reiter A et al
109354901999ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5.Smedley D et al
94994161998The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.Smedley D et al
108871372000ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.Xiao S et al
94259081998FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.Xiao S et al

Summary

Fusion gene

ZMYM2/FGFR1 ZMYM2 (13q12.11) FGFR1 (8p11.23) M t(8;13)(p11;q12)|ZMYM2/FGFR1 ZMYM2 (13q12.11) FGFR1 (8p11.23) TIC
Atlas Image
t(8;13)(p12;q12) G- banding - Top: Courtesy Melanie Zenger and Claudia Haferlach; Middle and bottom: Courtesy Charles Bangs and Patty Jones.

Citation

Marie-Josçphe Pébusque ; Marie-Josçphe Pébusque

t(8;13)(p11;q12) ZMYM2/FGFR1

Atlas Genet Cytogenet Oncol Haematol. 2000-12-01

Online version: http://atlasgeneticsoncology.org/haematological/1094/cancer-prone-explorer/case-report-explorer/gene-fusions-explorer/

Historical Card

1998-03-01 t(8;13)(p11;q12) ZMYM2/FGFR1 by  Dominique Leroux,Alain Bernheim,Jean-Loup Huret 

Lymphoma Research Group - Groupe de Recherche sur les Lymphomes, Institut Albert Bonniot, La Tronche 38706, France (DL)